CathVision ApS
9
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
67%
4 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
P-wave Duration and Local Potential as Predictors of AF Recurrence Following Pulmonary Vein Isolation
Role: lead
Measuring Local Potentials in PFA. MULTI PFA (EU)
Role: lead
The Automated Calculation of AF Cycle Length and Complexity Using a Novel EP Recording System
Role: lead
Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation REFINE-PFA
Role: lead
Single Center Pilot Study Using the ECGenius System to Collect Electrogram Data to Test an Ablation Impact Algorithm
Role: lead
Local Potential Measurement In PFA: A Pilot Study
Role: lead
An Evaluation of the Safety and Performance of the CathVision ECGenius® System.
Role: lead
Automated Assessment of PVI Using a Novel EP Recording System
Role: lead
An Evaluation of the Safety and Performance of the CathVision Cube® System
Role: lead
All 9 trials loaded